— U.S. FDA Grants Investigational New Drug Authorization to Study Remdesivir for the Treatment of COVID-19 — FOSTER CITY, Calif.–(BUSINESS WIRE)–Feb. 26, 2020– Gilead Sciences, Inc. (Nasdaq: GILD) today announced the initiation of two...
Feb 26, 2020 (Financial News Media via COMTEX) — FN Media Group Presents USA News Group News Commentary Los Angeles, CA – February 26, 2020 – USA News Group – An “exceedingly low” percentage of patients with cancer enroll in clinical...
GREENWOOD VILLAGE, Colo. & JERUSALEM, February 25, 2020 (Newswire.com) – ANANDA Scientific Inc., together with HADASSAH Medical Hospital, today announced the successful completion of subjects’ dosing in the first human clinical trial being conducted at...
A randomized, controlled clinical trial to evaluate the safety and efficacy of the investigational antiviral remdesivir in hospitalized adults diagnosed with coronavirus disease 2019 (COVID-19) has begun at the University of Nebraska Medical Center (UNMC) in Omaha....
Bristol-Myers Squibb announced five-year follow-up data from the Phase III CheckMate-025 trial, which continued to show that Opdivo (nivolumab) delivered superior overall survival (OS) and objective response rates (ORR) in patients with previously treated advanced or...
PDF Version Patient Analyses and Safety Data Continue to Underscore Positive Impact of KD025 in cGVHD Pre-NDA Meeting with FDA Planned for March 2020; Topline Results of Primary Analysis to be Announced in Q2 2020 NEW YORK, NY / ACCESSWIRE / February 23, 2020 / Kadmon...
Email
Text